SubHero Banner

Mylan – Recall of Semglee® (insulin glargine injection)

 On January 19, 2022, the FDA announced a consumer-level recall of one batch of Mylan’s (a Viatris  company) non-interchangeable Semglee (insulin glargine injection) prefilled pens which are packaged in  a labeled carton of five pens because of the potential for the label to be missing on some prefilled pens  within a labelled carton for this batch. 

Download PDF